Medical oncology laboratory

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


No photo of Robin Beekhof

Robin Beekhof

Person: Academic

No photo of Ceci Bergonzini

Ceci Bergonzini

Person: Academic

No photo of Maxime Blijlevens

Maxime Blijlevens

Person: Academic


Research Output

3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma

Cascioferro, S., Li Petri, G., Parrino, B., el Hassouni, B., Carbone, D., Arizza, V., Perricone, U., Padova, A., Funel, N., Peters, G. J., Cirrincione, G., Giovannetti, E. & Diana, P., 2020, In : Molecules. 25, 2, E329.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function

Van Der Steen, N., Keller, K., Dekker, H., Porcelli, L., Honeywell, R. J., Van Meerloo, J., Musters, R. J. P., Kathmann, I., Frampton, A. E., Liu, D. S. K., Ruijtenbeek, R., Rolfo, C., Pauwels, P., Giovannetti, E. & Peters, G. J., 1 Jan 2020, In : Journal of Cellular Physiology.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Functional genomic screen in mesothelioma reveals that loss of function of BRCA1-associated-protein-1 induces chemoresistance to ribonucleotide reductase inhibition

Okonska, A., Bühler, S., Rao, V., Ronner, M., Blijlevens, M., van der Meulen-Muileman, I. H., de Menezes, R. X., Wipplinger, M., Oehl, K., Smit, E. F., Weder, W., Stahel, R. A., Penengo, L., van Beusechem, V. W. & Felley-Bosco, E., Feb 2020, In : Molecular Cancer Therapeutics. 19, 2, p. 552-563 12 p.

Research output: Contribution to journalArticleAcademicpeer-review


  • 3 Examination
  • 3 Oral presentation
  • 2 Editorial work

Clinical and Experimental Immunology (Journal)

Tanja de Gruijl (Reviewer)
1 Jan 2018

Activity: Publication peer-review and editorial workEditorial work

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma

LL Meijer (Speaker), C Caparello (Speaker), TYS Le Large (Speaker), BM Zonderhuis (Speaker), F Daams (Speaker), E Giovannetti (Speaker), G Kazemier (Speaker)
May 2017

Activity: Talk or presentationOral presentation